Current Opinion in Neurology

Article	Citations
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation	76
Management of neuropsychiatric symptoms in dementia	68
Update on management of cerebral venous thrombosis	62
Assessing treatment response in multiple sclerosis	52
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis	50
The recent surge of functional movement disorders: social distress or greater awareness?	49
Editorial introductions	48
From basic mechanisms to therapeutic perspectives in cluster headache	47
Neuro-oncology is moving quickly toward new horizons of diagnosis and treatment	45
Hereditary motor neuropathies	40
Historical development and contemporary use of neuromodulation in human spinal cord injury	40
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies	39
Gene therapies for CMT neuropathies: from the bench to the clinic	38
Microglia in multiple sclerosis – pathogenesis and imaging	37
Decoding Alzheimer's disease through down syndrome: insights from a genetically defined population	35
Neurology education in the era of artificial intelligence	35
Integration over reduction: multimodal PET and fluid biomarkers in Alzheimer's disease and beyond	31
Central nervous system adverse events of immune checkpoint inhibitors	30
Neurosyphilis in 2025: Erratum	30
The role of the gut microbiome in Alzheimer's disease pathophysiology	29
Editorial introductions	28
The 2021 WHO classification of central nervous system tumors: what neurologists need to know	28
Updates in neuro-otology	28
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection	26
Editorial: Epilepsy advances in 2023	26

New chronic inflammatory demyelinating polyneuropathy/Guillain–Barré syndrome guidelines – impact on clinical practise	26
Multiple sclerosis in China: the current state of diagnosis and management	26
Development of neural repair therapy for chronic spinal cord trauma: soluble Nogo receptor decoy from discovery to clinical trial	25
Connecting tremors – a circuits perspective	24
Update on the clinical and therapeutic aspects of myotonic dystrophy type 1	24
Thymectomy in myasthenia gravis	23
Burning vertex syndrome: a novel unclassified headache - its preliminary observations, and possible mechanisms	23
Threat of resurgence or hope for global eradication of poliovirus?	22
Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery	22
COVID-19 related headaches: epidemiology, pathophysiology, impacts, and management	22
The FSHD jigsaw: are we placing the tiles in the right position?	22
Migraine in women: a review	21
Tuberculosis of the central nervous system: current concepts in diagnosis and treatment	21
Revascularization of arterial occlusions in posterior circulation acute ischemic stroke	21
Levodopa infusion therapies for Parkinson disease	21
Clinical impact of molecular profiling in rare brain tumors	21
Nerve ultrasound in the diagnosis of inflammatory neuropathies	21
Red flags in multiple sclerosis	20
Global to individual: key domains of burden in pediatric headache	20
MRI in multiple sclerosis: progress in in-vivo pathobiology	19
Novel pharmacological therapies in development	19
Diet and migraine: what is proven?	19
Galectins in the brain: advances in neuroinflammation, neuroprotection and therapeutic opportunities: Erratum	19
Update on dermatomyositis	19
Obesity-related neuropathy: the new epidemic	19
Idiopathic intracranial hypertension: expanding our understanding	19
fMRI-based spatio-temporal parcellations of the human brain	19
Acute stroke care in low and middle-income countries	18
Targeting IDH1/IDH2 mutations in gliomas	18
MRI for the diagnosis of limb girdle muscular dystrophies	18
Parkinson's disease – genetic cause	18
Electrical stimulation of the peripheral and central vestibular system	18
Gauging and controlling excitability in cortical disorders	18
Editorial: The gap between academic advances and therapy development in motor neuron disease	18
Neurosyphilis in 2025	17
Progress in spinal muscular atrophy research	17
Novel approaches to treatment of leptomeningeal metastases	17
New developments in diagnostics and treatment of adult-onset focal dystonia	17
Susceptibility and disease modifier genes in amyotrophic lateral sclerosis: from genetic associations to therapeutic implications	17
Recent advances in Alzheimer disease genetics	17
Editorial introductions	17
Sex and gender differences in neurological infections	16
Autoimmune encephalitis and paraneoplastic neurologic syndrome: clinical diagnosis	16
Neuroinflammation and immunometabolism in neurodegenerative diseases	16
Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management	16
Towards multimodal cognition-based treatment for cognitive impairment in Parkinson's disease: drugs, exercise, non-invasive brain stimulation and technologies	16
Optic neuritis: current challenges in diagnosis and management	16
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers	16
Choroid plexuses at the interface of peripheral immunity and tissue repair in multiple sclerosis	16
The state of art on the use of patient reported outcomes in migraine	15

Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health	15
Diagnosing viral encephalitis and emerging concepts	15
Monitoring multiple sclerosis: digital and fluid phase biomarkers	15
Chronic idiopathic axonal neuropathy: antibodies, genetics, and beyond	15
PET imaging of microglial pathology in multiple sclerosis	14
New insights in the immune treatment of Guillain–Barré syndrome	14
Current trend in air pollution exposure and stroke	14
The monoaminergic systems as drivers of Alzheimer's disease pathophysiology and symptomatology	14
Update on genetics of amyotrophic lateral sclerosis	14
Abnormal energy metabolism in ALS: a key player?	14
Precision medicine in Moyamoya vasculopathy	14
Recent insights in striated muscle laminopathies	14
Fluid phase biomarkers in multiple sclerosis	14
Imaging of vestibular function and disorders and its clinical relevance	14
Vestibular migraine. Clinical and diagnostic challenges, and emerging therapeutic approaches	13
Editorial introductions	13
Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum	13
Challenges in studying disparities in neuropsychiatric hyperkinetic movement disorders	13
Converging perspectives in vestibular neurology	13
Imaging cortical lesions in multiple sclerosis	13
Progress in the mechanism of neuronal surface P antigen modulating hippocampal function and implications for autoimmune brain disease: Erratum	13
Update on modifiable risk factors for Alzheimer's disease and related dementias	13
Long COVID and especially headache syndromes	12
Recent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease	12
Immune checkpoint inhibitors induced side effects of the peripheral nervous system	12
Current gaps in acute reperfusion therapies	12
Myofibrillar myopathy: towards a mechanism-based definition as a Z-disk-opathy	12
Editorial: Seizure disorders: 2023 update	12
Peripheral visual field loss and activities of daily living	11
Genetic role in autoimmune encephalitis and paraneoplastic neurological syndromes	11
Editorial: Innovation and resilience in movement disorders: abundance of creative science despite the covid-19 period	11
Progress in treatment of gliomas	11
Editorial introductions	11
Life after autoantibody-mediated encephalitis: optimizing follow-up and management in recovering patients	11
Deep brain stimulation of the mesencephalic locomotor region or lateral hypothalamus for facilitation of walking after spinal cord injury	11
Editorial: Cerebrovascular disease	11
In-vivo diagnosis of cerebral amyloid angiopathy: an updated review	11
Muscle ultrasound in myopathies	11
Nonneurologic causes of binocular diplopia for the neurologist	11
Update on functional vestibular and gait disorders	11
An update on psychogenic nonepileptic seizures	10
Editorial introductions	10
Emerging concepts and therapies for amyotrophic lateral sclerosis	10
Neuro-infectious disorders – reasons to be cheerful but it is a long and winding road	10
Assessing the efficacy of duration and intensity prescription for physical activity in mitigating cardiometabolic risk after spinal cord injury	10
Perception and control of a virtual body in immersive virtual reality for rehabilitation	10
Therapeutic thoroughfares for adults living with Pompe disease	10
Acute vertigo: stroke or not?	10
Editorial: Advances in brain tumors management: new perspectives and challenges	10
Interrogating large multiple sclerosis registries and databases: what information can be gained?	10
Update on novel multiple sclerosis treatments: from dismal defeat to scintillating success	10
Is calcitonin gene-related peptide a reliable biochemical marker of migraine?	10
Editorial introductions	10
Barriers to clinical genetic testing in movement disorders	10
Multiple sclerosis: advances and challenges in diagnosis	10
Progression in multiple sclerosis – a long-term problem	10
The current landscape of epilepsy genetics: where are we, and where are we going?	9
Atypical forms of Alzheimer's disease: patients not to forget	9
Deep brain stimulation access in 2025: geographic, gender, racial, and socioeconomic disparities re-examined	9
Progressive supranuclear palsy: current approach and challenges to diagnosis and treatment	9
Editorial:Framing artificial intelligence to neuromuscular disorders	9
Editorial introductions	9
How to evaluate extent of resection in diffuse gliomas: from standards to new methods	9
AI in epilepsy neuroimaging	9
New targets in spontaneous intracerebral hemorrhage	9
Editorial improving movement disorders healthcare across the globe	9
Artificial intelligence in neuroimaging of brain tumors: reality or still promise?	8
Guillain-Barré syndrome in an era of global infections and 21st century vaccination	8
Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications	8
Endogenous clues promoting remyelination in multiple sclerosis	8
Shifting our attention earlier in the multiple sclerosis disease course	8
Editorial: Current opinions in neurology editorial	8
PET-based brain molecular connectivity in neurodegenerative disease	8
Congenital myasthenic syndromes: increasingly complex	8
Lesion network mapping for symptom localization: recent developments and future directions	8
Imaging and neuromodulation in Parkinson's disease	8
New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome	8
Promises and pitfalls of imaging-based biomarkers in motor neuron diseases	8
The role of caffeine in headache disorders	7
Recent insights into haematology and peripheral nerve disease	7

Investigational approaches to multiple sclerosis therapy	7
Ultra-high dose methylcobalamin and other emerging therapies for amyotrophic lateral sclerosis	7
Autoimmune neuromyotonia	7
Recent advances in stroke biomarkers – implications for prognosis and treatment	7
Headache in infections	7
The genetics of multiple sclerosis: an updated perspective	7
Leprous neuropathy	7
Editorial: Update on movement disorders	7
Clinical amyloid and tau positron emission tomography imaging in Alzheimer's disease: image interpretation in the era of anti-amyloid therapies	7
The genetics of amyotrophic lateral sclerosis	7
Editorial introductions	6
Editorial introductions	6
Neuroimaging endpoints for clinical trials in gliomas: the neuro-oncologist perspective	6
Recent advances in the genetics of Parkinson's disease in underrepresented populations	6
An update on multiple system atrophy	6
Genetics of ALS – genes and modifier	6
Emerging neuroinfectious diseases: public health implications	6
Characterization, etiology, and management of neurocognitive impairment in patients with glioma: an evidentiary update	6
Clinical characteristics of patients with myelin oligodendrocyte glycoprotein antibodies	6
Autoimmune nodopathies, an emerging diagnostic category	6
Novel pathophysiological insights in autoimmune myasthenia gravis	6
Brain health in HIV: pathogenesis, classification, and treatment	6
Medical and neurologic management of brain tumor patients	6
Progress in the mechanism of neuronal surface P antigen modulating hippocampal function and implications for autoimmune brain disease	6
Recent advances in epilepsy surgery	6
Update on myelin imaging in neurological syndromes	6
Big data in multiple sclerosis	5
Movement disorders in COVID-19 times: impact on care in movement disorders and Parkinson disease	5
The evolving spectrum of complex inherited neuropathies	5
Spasticity following brain and spinal cord injury: assessment and treatment	5
Ambulatory seizure detection	5
Persistent aura without infarction	5
Advances in myopathy research: promising developments and challenges	5
Assessment and treatment of neurogenic dysphagia in stroke and Parkinson's disease	5
Promoting exogenous repair in multiple sclerosis: myelin regeneration	5
Pathomechanisms in demyelination and astrocytopathy: autoantibodies to AQP4, MOG, GFAP, GRP78 and beyond	5
Epilepsy advances in 2025	5
Recent developments in multiple sclerosis neuropathology	5
Vestibular syncope	5
Current understanding of skeletal muscle repeat expansion disorders	5
Does imaging of the ischemic penumbra have value in acute ischemic stroke with large vessel occlusion?	5
The challenge of amyotrophic lateral sclerosis descriptive epidemiology: to estimate low incidence rates across complex phenotypes in different geographic areas	5
Editorial introductions	5
Novel trial designs in neuro-oncology	5
Defining the presymptomatic phase of frontotemporal dementia	5
Heterogeneity of frequencies of motor neuron disease across ethnicities and geographical areas: focus on Arabic countries in the Mediterranean area	5
Mechanisms of paraneoplastic neurological syndromes	5
Neurotoxicity from chimeric antigen receptor T-cells: an update on diagnosis and treatment	5
Current drug treatment of myasthenia gravis	5
Systemic vasculitis and headache	5
The current clinical perception of myotonic dystrophy type 2	5
Recent advances, challenges and perspectives in cerebrovascular disease	5
Diagnostic criteria for amyotrophic lateral sclerosis	4
The atypical faces of optic neuritis: neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease	4
Traumatic peripheral nerve injuries: diagnosis and management	4
Neuroscience and oncology: state-of-the-art and new perspectives	4
Editorial: Neuromuscular diseases: differential diagnosis and targeted treatment	4
Somatic mosaicism in focal epilepsies	4
Immunology of multiple sclerosis: an update	4
Reproducibility and replicability in neuroimaging data analysis	4
Parkinson's disease – current treatment	4
Noninvasive brain stimulation to improve motor outcomes after stroke	4
Traumatic brachial plexus injury: diagnosis and treatment	4
The impact of climate change on neuroinfectious diseases	4
Recent advances in our understanding of genetic rhabdomyolysis	4
Updates for newly diagnosed and recurrent glioblastoma: a review of recent clinical trials	4
Enzyme replacement therapies in adults with Pompe disease: from trials to real-world data	4
How can you manage an indomethacin-responsive headache in someone who cannot take indomethacin?	4
Nerve ultrasound for the diagnosis and follow-up of peripheral neuropathies	4
Small fiber neuropathy: expanding diagnosis with unsettled etiology	4
The cortical vestibular system: insights from electroencephalography	4
Advances in functional and structural imaging of the brainstem: implications for disease	4
Noninvasive methods to monitor intracranial pressure	4
Neuro-vestibular rehab: new developments	4
Late-onset myopathies	4
Imaging of sleep disorders in pre-Parkinsonian syndromes	4
Describing and assessing behavioural symptoms in amyotrophic lateral sclerosis with and without frontotemporal dementia: a scoping review	4